William Cavanagh - IsoRay Vice President - Research and Development
ISRDelisted Stock | USD 0.38 0.01 2.70% |
President
Mr. William Cavanagh, III is Chief Research and Development Office of the Company since February 2019. He joined IsoRay Medical, Inc. in January 2010 and served as Vice President, Research and Development until March 3, 2016, other than serving as interim Chief Executive Officer for IsoRay from January 7, 2016 to February 14, 2016. He was appointed Chief Operating Officer of IsoRay effective March 3, 2016 and Chief Scientific Officer effective August 15, 2016. Immediately prior to joining IsoRay Medical, Mr. Cavanagh was engaged in the research and development of dendritic cell therapies for cancer and infectious diseases. He served as Chief Scientific Officer for Sangretech Biomedical, LLC for the six years prior to joining IsoRay Medical. At Sangretech, he oversaw the design and implementation of a novel cancer therapy. Mr. Cavanagh began his extensive career in cancer treatment technologies in the early 1990s, when he helped lead research and development of a therapy involving the insertion of radioactive sources directly into the prostate for the treatment of prostate cancer . He has designed several cancer treatmentrelated studies, is listed as an author on 34 peerreviewed publications, and is the listed inventor on a U.S. patent application detailing a novel treatment for cancer. Mr. Cavanagh has also served as Director of the Haakon Ragde Foundation for Advanced Cancer Studies in Seattle, Washington, where he led the research foundation in the selection of viable research projects directed at treating advanced cancers since 2019.
Age | 53 |
Tenure | 5 years |
Phone | 509 375 1202 |
Web | https://isoray.com |
IsoRay Management Efficiency
The company has Return on Asset of (0.1085) % which means that on every $100 spent on assets, it lost $0.1085. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1741) %, meaning that it generated no profit with money invested by stockholders. IsoRay's management efficiency ratios could be used to measure how well IsoRay manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | PRESIDENT Age | ||
Darrin Siver | PACCAR Inc | 57 | |
James Lane | Marine Products | 71 | |
Joseph Matthews | Gentex | 48 | |
Harrie Schippers | PACCAR Inc | 61 | |
Brad Bosma | Gentex | N/A | |
Jack LeVier | PACCAR Inc | 58 | |
Lily Ley | PACCAR Inc | 58 | |
Jason Brooks | Rocky Brands | 52 | |
Neil Boehm | Gentex | 52 | |
Benjamin Palmer | Marine Products | 60 | |
Richard Simms | Rocky Brands | 50 | |
Preston Feight | PACCAR Inc | 56 | |
Steve Downing | Gentex | 37 | |
James Clack | PACCAR Inc | 52 | |
David Anderson | PACCAR Inc | 61 | |
Matthew Chiodo | Gentex | 58 | |
Jason Skoog | PACCAR Inc | 46 | |
Samuel Means | PACCAR Inc | 46 | |
Michael Barkley | PACCAR Inc | 69 | |
Gary Moore | PACCAR Inc | 62 | |
Michael Dozier | PACCAR Inc | 58 |
Management Performance
Return On Equity | -0.17 | |||
Return On Asset | -0.11 |
IsoRay Inc Leadership Team
Elected by the shareholders, the IsoRay's board of directors comprises two types of representatives: IsoRay inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IsoRay. The board's role is to monitor IsoRay's management team and ensure that shareholders' interests are well served. IsoRay's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IsoRay's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mark Austin, Principal Accounting Officer, Co-Principal Financial Officer, Controller | ||
Alan Hoffmann, Independent Director | ||
Lisa Lauer, Vice President - Business Development | ||
Lori Woods, Interim Chief Executive Officer, Director | ||
Michael McCormick, Independent Chairman of the Board | ||
Jonathan Hunt, Chief Financial Officer, Co-Principal Financial Officer | ||
Thomas LaVoy, Independent Director | ||
William Cavanagh, Vice President - Research and Development | ||
Lori HolmesWoods, CEO Director | ||
Michael Krachon, Vice President, Director of Sales and Marketing | ||
Jennifer Streeter, Interim Chief Operating Officer, Vice President of Human Resources | ||
Mark CPA, Controller, Fin | ||
William III, Chief Officer | ||
Philip Vitale, Independent Director | ||
Krista Cline, Senior Director of Operations, Corporate Secretary | ||
Matthew Branson, Principal Financial Officer | ||
Patricia Mills, NE Area Sales Director | ||
Brien Ragle, CFO |
IsoRay Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is IsoRay a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.17 | |||
Return On Asset | -0.11 | |||
Profit Margin | (1.16) % | |||
Operating Margin | (1.21) % | |||
Current Valuation | (11.02 M) | |||
Shares Outstanding | 278.66 M | |||
Shares Owned By Insiders | 0.76 % | |||
Shares Owned By Institutions | 6.18 % | |||
Number Of Shares Shorted | 409.25 K | |||
Price To Earning | (5.00) X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in IsoRay Stock
If you are still planning to invest in IsoRay Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IsoRay's history and understand the potential risks before investing.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |